BEDFORD, Mass., Feb. 20 /PRNewswire-FirstCall/ -- Insulet Corporation, , the leader in wearable insulin pump technology with its OmniPod(R) Insulin Management System, announced plans to release its financial results for the fourth quarter and full year 2007 on Monday, March 17, 2008 after the close of the financial markets.
Insulet will also host a conference call at 8:00 a.m. Eastern Time on Tuesday, March 18, 2008 to discuss its fourth quarter and full year 2007 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.
To listen to the conference call, please dial 866.314.5232 for domestic callers and 617.213.8052 for international callers. The passcode is 86189075. A replay of the conference call will be available two hours after the start of the call through April 18, 2008 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 17622814. An online archive of the conference call will also be available by accessing the Investor Information section of the company’s website at http://investors.insulet.com.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company’s OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.
ir@insulet.com
CONTACT: Stephanie Marks for Insulet Corporation, +1-877-PODD-IR1
(877-763-3471), ir@insulet.com
Web site: http://investors.insulet.com/
